New search Hide text from Guidelines
R RESPIRATORY SYSTEMInhaled antiinfectives are classified in ATC group J - Antiinfectives for systemic use.
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
This group comprises all drugs for obstructive airway diseases for inhalation excl. adrenergics (R03A).
| See comment under R03A. |
R03BB Anticholinergics
Combinations with adrenergics are classified in R03AL.
The combination of tiotropium bromide and ciclosonide is classified in R03BB54.
| The DDDs are based on the maintenance treatment of asthma. The DDDs for tiotropium bromide and umeclidinium bromide are based on treatment of COPD (Chronic Obstructive Pulmonary Disease). The DDD for tiotropium bromide inhalation powder is based on tiotropium, delivered dose. The DDD for aclidinium bromide inhalation powder is based on aclidinium, delivered dose. The DDD for glycopyrronium bromide inhalation powder is based on glycopyrronium, delivered dose. The DDD for umeclidinium bromide inhalation powder is based on umeclidinium, delivered dose. |
| ATC code | Name | DDD | U | Adm.R | Note |
| R03BB01 | ipratropium bromide | 0.12 | mg | Inhal.aerosol | |
| 0.12 | mg | Inhal.powder | |||
| 0.3 | mg | Inhal.solution | |||
| R03BB02 | oxitropium bromide | 0.6 | mg | Inhal.aerosol | |
| 4 | mg | Inhal.solution | |||
| R03BB03 | stramoni preparations | ||||
| R03BB04 | tiotropium bromide | 10 | mcg | "Inhal.powder" | Expressed as tiotropium, delivered dose |
| 5 | mcg | Inhal.solution | |||
| R03BB05 | aclidinium bromide | 0.644 | mg | "Inhal.powder" | Expressed as aclidinium, delivered dose |
| R03BB06 | glycopyrronium bromide | 44 | mcg | "Inhal.powder" | Expressed as glycopyrronium, delivered dose |
| R03BB07 | umeclidinium bromide | 55 | mcg | "Inhal.powder" | Expressed as umeclidinium, delivered dose |
| R03BB08 | revefenacin | ||||
| R03BB54 | tiotropium bromide, combinations |
Last updated: 2024-01-26